Trial Update November 12, 2026

Tirzepatide Phase 4 Trial Status Updated: Active, Not Recruiting

A status update for a tirzepatide clinical trial was recorded on November 12, 2026. The study, titled "A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes," is registered as NCT05433584. This is a Phase 4 trial. Its current status is listed as active, not recruiting. This means the study is ongoing but is no longer enrolling new participants. Tirzepatide is an approved compound, and this trial compares it against intensified conventional care in adults with type 2 diabetes. No results or outcome data have been reported as part of this update. The trial record does not state when results may become available. This brief reflects only the status change documented in the trial registry entry. For more background on tirzepatide, readers can consult the compound overview.

See the full tirzepatide overview

Source: https://clinicaltrials.gov/study/NCT05433584